We subsequently assessed A2‐like (S100a10+/GFAP+) astrocytes in the peri‐infarct region at 7 days post‐stroke and discovered a noteworthy increase in the 3‐HKA‐treated group compared with the vehicle‐treated group (Figure 4c,d). This evidence concerns the gene S100A10 and stroke disorder.